FREE LIVE WEBINAR

December 3, 2026 | 12:00–1:00 PM (EST)

FDA Medical Device Inspections: Current Trends, Expectations & QMSR Implications

FDA medical device inspections have entered a new era. With the Quality Management System Regulation (QMSR) taking effect on February 2, 2026, the FDA has replaced its longstanding Quality System Inspection Technique (QSIT) with a new risk-based inspection approach. For manufacturers of all sizes, understanding these changes is essential to maintaining compliance and inspection readiness.

Join regulatory expert and former FDA official Kim Trautman for an inside look at the evolving FDA inspection landscape and what it means for manufacturers of medical devices, IVDs, and combination products with device constituent parts.

Drawing on decades of regulatory experience, Kim will explore current inspection trends, investigator expectations, and recent FDA Warning Letter findings. She’ll also discuss how the QMSR is reshaping inspection practices, why integrated risk management matters more than ever, and what manufacturers can do to demonstrate a strong culture of quality.

In this webinar, you’ll learn:

  • Current FDA inspection trends: What investigators are focusing on under the new QMSR-aligned inspection process and what recent Warning Letters reveal about compliance expectations.
  • Risk management expectations: Why integrating risk management throughout your quality management system is essential and how to avoid disconnected, siloed processes.
  • MDSAP implications: How a decade of Medical Device Single Audit Program (MDSAP) audits is influencing FDA oversight, including considerations for Class II and lower-risk devices.
  • Demonstrating a culture of quality: Practical examples of documented evidence that can help demonstrate effective quality management practices and strengthen inspection readiness.

Gain valuable insight into what FDA investigators expect today and how your organization can better prepare for its next inspection. 

Register for Free!

QuickVault logo in blue

QuickVault by Veeva is the leading eQMS solution for MedTech companies. Built for full device lifecycle support, the platform unifies design, regulatory, quality, and post-commercial operations in one scalable environment, helping teams stay agile, compliant, and ready to grow.

From concept through commercialization and beyond, QuickVault by Veeva gives MedTech companies the visibility and control they need to deliver safe, effective products to patients and succeed at every stage.